GEHC monthly performance report
Check GEHC's monthly returns, drawdown, and seasonality trends — updated every month.
GEHC monthly report
—
Key takeaways
- GE HealthCare (GEHC) closed September 2026 at $63.49, down 10.87% for the month and −18.06% over the trailing 12 months.
- Year-to-date, GEHC is −22.59%, underperforming the S&P 500 which has returned +10.58% YTD.
- The stock is trading −12.52% versus its 200-day moving average ($72.58), a cautious technical signal.
- Over the past three years, GEHC has underperformed the S&P 500 by −74.50%, with a relative strength index reading of 56.4.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
GE HealthCare ended September 2026 at $63.49, posting a monthly return of −10.87%. The S&P 500 returned −1.69% over the same window, leaving relative performance at −9.17%.
The current quarter stands at −0.81% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −12.52% versus the 200-day moving average ($72.58).
Year-to-date, GEHC is −22.59% against SPY +10.58%, a gap of −33.17%. The stock is currently −29.27% below its 52-week high, with maximum 3-year drawdown at −37.41%.
| Period | GEHC | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.91% | −0.44% | −0.46% |
| 1 Week | −2.58% | −1.10% | −1.48% |
| 1 Month | −10.87% | −1.69% | −9.17% |
| 3 Months | −1.58% | −0.10% | −1.48% |
| 6 Months | −12.70% | +13.21% | −25.92% |
| YTD | −22.59% | +10.58% | −33.17% |
| 12 Months | −18.06% | +14.25% | −32.31% |
| 3 Years | −4.43% | +70.07% | −74.50% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2024 | +24.43% |
| #2 | Jan 2025 | +12.94% |
| #3 | Dec 2023 | +12.94% |
| #4 | Sep 2024 | +10.65% |
| #5 | Jul 2024 | +8.61% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2024 | −16.14% |
| #2 | Mar 2026 | −15.53% |
| #3 | Apr 2026 | −14.53% |
| #4 | Apr 2025 | −12.86% |
| #5 | Sep 2026 | −10.87% |
| Quarter | Return |
|---|---|
| Q2 2025 | −8.23% |
| Q3 2025 | +1.39% |
| Q4 2025 | +9.21% |
| Q1 2026 | −13.22% |
| Q2 2026 | −10.07% |
| Q3 2026 (QTD) | −0.81% |
| Year | Return |
|---|---|
| 2023 | +32.44% |
| 2024 | +1.11% |
| 2025 | +4.91% |
| 2026 | −22.59% |
| Metric | Value |
|---|---|
| 52-Week High | $89.77 (2026-01-08) |
| 52-Week Low | $58.75 (2026-04-29) |
| Current Price | $63.49 |
| 200-Day Moving Average | $72.58 |
| Price vs 200DMA | −12.52% |
| 3-Year Maximum Drawdown | −37.41% (2025-04-08) |
| Current Drawdown from 52W High | −29.27% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 56.4 |
| 3-Year Excess Return vs S&P 500 | −74.50% |
| RS Peak | 123 (Feb 2024) |
| RS Trough | 54.5 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was GEHC's return for this report period?
GEHC returned −10.87% in the latest monthly window ending 2026-09-16.
Has GEHC outperformed SPY year to date?
YTD GEHC: −22.59% vs SPY: +10.58%.
What is GEHC's 12-month return?
−18.06% over the trailing 12 months.
Is GEHC above or below its 200-day moving average?
Price is −12.52% versus 200DMA ($72.58).
What is the maximum drawdown in the 3-year window?
−37.41% on 2025-04-08.